Vitamin D status does not influence disability progression of multiple sclerosis patients over three years follow-up

被引：0
|
作者：
Muris, A. -H. [1 ,2 ]
Smolders, J. [2 ]
Rolf, L. [1 ,2 ]
Klinkenberg, L. [3 ]
van der Linden, N. [3 ]
Meex, S. [3 ]
Damoiseaux, J. [3 ]
Hupperts, R. [1 ,2 ]
机构：
[1] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands
[2] Orbis Med Ctr, Acad MS Ctr Limburg, Sittard, Netherlands
[3] Maastricht Univ, Med Ctr, Cent Diagnost Lab, NL-6200 MD Maastricht, Netherlands
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P400
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [21] Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years
    Zivadinov, R.
    Hojnacki, D.
    Bergsland, N.
    Kennedy, C.
    Hagemeier, J.
    Melia, R.
    Ramasamy, D. P.
    Durfee, J.
    Carl, E.
    Dwyer, M. G.
    Weinstock-Guttman, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (06) : 1101 - 1109
  • [22] Longitudinal follow-up of "benign" multiple sclerosis at 20 years
    Sayao, Ana-Luiza
    Devonshire, Virginia
    Tremlett, Helen
    NEUROLOGY, 2007, 68 (07) : 496 - 500
  • [23] Longitudinal follow-up of "benign" multiple sclerosis at 20 years
    Amato, Maria Pia
    De Stefano, Nicola
    NEUROLOGY, 2007, 69 (09) : 938 - 938
  • [24] Vitamin D status and disability among patients with multiple sclerosis: a systematic review and meta-analysis Running title: Vitamin D status and MS disability
    Moosazadeh, Mahmood
    Nabinezhad-Male, Fatemeh
    Afshari, Mandi
    Nasehi, Mohammad Mehdi
    Shabani, Mohammad
    Kheradmand, Motahareh
    Aghaei, Iraj
    AIMS NEUROSCIENCE, 2021, 8 (02) : 239 - 253
  • [25] Cortical thinning in patients with multiple sclerosis: a follow-up study after 9 years
    Sailer, Michael
    Tempelmann, Claus
    Stadler, Erhard
    Matzke, Mike
    Schoenfeld, Ariel
    Heinze, Hans-Jochen
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S217 - S217
  • [26] Treatment outcome of alemtuzumab in Korean patients with multiple sclerosis: 2 years follow-up
    Hyun, J. W.
    Shin, H. J.
    Park, N. Y.
    Jang, H.
    Kim, S. H.
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 465 - 465
  • [27] Contribution of MRI to the follow-up of multiple sclerosis patients
    Tourbah, A
    REVUE NEUROLOGIQUE, 2001, 157 (8-9) : 1124 - 1127
  • [28] Cortical and Subcortical Grey Matter Atrophy as Predictors of Disability Progression in Patients with Multiple Sclerosis: A 10-Year Follow-Up Study
    Jacobsen, Cecilie
    Bergsland, Niels
    Dalaker, Turi
    Farbu, Elisabeth
    Hagemeier, Jesper
    Larsen, Jan
    Lode, Kirsten
    Myhr, Kjell Morten
    Nyland, Harald
    Ramasamy, Deepa
    Zivadinov, Robert
    NEUROLOGY, 2013, 80
  • [29] Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: A follow-up study
    de Carvalho Jennings Pereira, Wildea Lice
    Flauzino, Tamires
    Alfieri, Daniela Frizon
    Oliveira, Sayonara Rangel
    Kallaur, Ana Paula
    Colado Simao, Andrea Name
    Batisti Lozovoy, Marcell Alysson
    Kaimen-Maciel, Damacio Ramon
    Maese, Michael
    Vissoci Reiche, Edna Maria
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 410
  • [30] Progression of brain atrophy over 10 years and its relationship to disability change in patients with multiple sclerosis
    Giorgio, A.
    Stromillo, M. L.
    Bartolozzi, M. L.
    Rossi, F.
    Battaglini, M.
    Blandino, A.
    Guidi, L.
    Maritato, P.
    Federico, A.
    De Stefano, N.
    JOURNAL OF NEUROLOGY, 2011, 258 : 152 - 152
12345